Vira Shield 6 L5

Vira Shield® 6 + L5 is for use in healthy breeding cattle, including pregnant cows and heifers, as an aid in the prevention of disease caused by infectious bovine rhinotracheitis (IBR), bovine virus diarrhea (BVD Types 1 & 2), parainfluenza Type 3 (PI3), and bovine respiratory syncytial (BRSV) viruses and Campylobacter fetusLeptospira canicolagrippotyphosahardjoicterohaemorrhagiae, and pomona. Produced from non-cytopathic (BVD Types 1 & 2) and cytopathic (BVD Type 1) isolates.

A killed virus and bacterin for the protection of healthy cattle against IBR, PI3, BRSV, cytopathic and noncytopathic BVD Type 1, noncytopathic BVD Type 2, and the 5 most common strains of Lepto, including the U.S. strain of L. hardjo-bovis. For use in all classes of cattle, even pregnant cows and calves nursing pregnant cows. Vaccinate dairy cows during the dry off period. Features Xtend SP adjuvant. Dosage: 5 ml administered subcutaneously, repeat in 4-5 weeks. Revaccinate annually. 60 day slaughter withdrawal. Anaphylactoid reactions may occur. Antidote: Epinephrine.

Description

Killed virus and bacterin for the protection of healthy cattle against IBR, PI3, BRSV, cytopathic and noncytopathic BVD Type 1, noncytopathic BVD Type 2 and the 5 most common strains of Lepto. Features Xtend SP adjuvant. Vaccinate dairy cows during the dry off period. Dosage: 5 ml subcut, revaccinate with Vira Shield 6 in 4-5 weeks. Revaccinate annually. 60 day slaughter withdrawal. U.S. Lic. No. 303.Active Ingredient: Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Vaccine-Killed Virus Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin For use in healthy cattle, including pregnant cows and heifers, as an aid in the prevention of disease caused by infectious bovine rhinotracheitis (IBR), bovine virus diarrhea (BVD Type 1 and BVD Type 2), parainfluenza Type 3 (PI3), and bovine respiratory syncytial (BRSV) viruses and Leptospira canicola, grippotyphosa, hardjo, icterohaemorrhagiae, and pomona. Produced from non-cytopathic (BVD Type 1 and BVD Type 2) and cytopathic (BVD Type 1) isolates.

Indications

For use in healthy cattle, including pregnant cows and heifers, as an aid in the prevention of disease caused by infectious bovine rhinotracheitis (IBR), bovine virus diarrhea (BVD Type 1 and BVD Type 2), parainfluenza Type 3 (PI3), and bovine respiratory syncytial (BRSV) viruses and Leptospira canicola, grippotyphosa, hardjo, icterohaemorrhagiae, and pomona. Produced from non-cytopathic (BVD Type 1 and BVD Type 2) and cytopathic (BVD Type 1) isolates.

Features of Vira Shield 6 L5

  • For use in all classes of cattle, even pregnant cows
  • The only vaccine with three BVD isolates: noncytopathic Types 1 & 2 and cytopathic Type 1
  • Provides a 12 month DOI against L. hardjo-bovis
  • Shown to deliver enhanced IBR fetal protection 8 months post-vaccination

Directions/Dosage:

  • Shake well before using
  • Administer 5 mL subcutaneously 2-4 weeks prior to breeding
  • In accordance with Beef Quality Assurance guidelines, this product should be administered subcutaneously (under the skin) in the neck
  • Revaccinate with Vira Shield® 6 + L5 HB in 4-5 weeks
  • Revaccinate annually or as recommended by your veterinarian

Prices of Vira Shield 6 L5

$49.51 – $106.93

Sharing is caring!

Leave a Comment

Your email address will not be published.

error: Content is protected !!